InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Ede Ronald Hao Xi, 管理人员. Insider active across 1 company, notably Innovent Biologics, Inc.. Cumulatively, 8 disclosures have been recorded. History available since 27 March 2026. The latest transaction was filed on 6 July 2026 (Sale). Regulator: HKEX. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Ede Ronald Hao Xi is a Dirigeant and Director of Innovent Biologics, Inc. The 7 filings recorded cover the period from 2026-04-02 to 2026-07-09, with 0 EUR of buys and 44,571,724 EUR of sales in the recent filings tracked.